PIEZO1 and metabolic dysfunction-associated steatotic liver disease: In the present study, IEC-specific deficiency of PIEZO1 alleviated HFD-induced liver steatosis, without change on glucose and energy metabolism, providing us with a new target for MASLD treatment.